Malignant hyperthermia: moving forward before the complications
Main Article Content
Keywords
Malignant hyperthermia, Duchenne Disease, Dantrolene
Abstract
Malignant hyperthermia (HTM) is a dominant autosomic pharmaco-genetic sickness of low incidence but potentially lethal, characterized by a hypermetabolic syndrome of the skeletal striated muscle, that may unchain its complete destruction, resulting in an increase of the body temperature, high oxigen consumption, hyperpotassemia, kidney failure and arrhythmias. Below we present the case of a 6 year old patient suffering from Duchenne muscular dystrophia, with family antecedents of malignant hyperthermia, who was subject to adenotonsillectomy surgery, where anesthetic measures were taken to prevent development of a crisis.
